Search

everythinglearnresearchcommunity

for

Search:↓

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Many research paper titles in dermatology journals lack scientific precision.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Ruxolitinib treatment may cause eyelash growth.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Platelet-rich plasma, taken from a person's own blood, can help rejuvenate skin, stimulate hair growth, and treat hair loss, but more research is needed to confirm its safety and effectiveness.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Psoralea corylifolia Linn. is a medicinal plant used for skin diseases and has various health benefits.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

Iron deficiency might contribute to hair loss in women.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Testosterone's effects on COVID-19 are unclear and need more research.